|
|
||||||||
1





* Division of Infectious Genetics, Institute of Medical Science, University of Tokyo, Tokyo, Japan;
Core Research for Engineering, Science, and Technology, Japan Science and Technology, Tokyo, Japan;
Laboratory of Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo, Japan; and
Technology and Development Team for BioSignal Program, Subteam for BioSignal Integration, RIKEN Bioresource Center, RIKEN Tsukuba Institute, Ibaraki, Japan
LPS is recognized by a heterodimer consisting of TLR4 and its coreceptor MD-2. LPS signal causes excessive inflammation and tissue damage. In this study, we show that a mAb to TLR4/MD-2 protected mice from acute lethal hepatitis caused by LPS/D-galactosamine. The protective effect of the mAb was not due to inhibition of LPS response, because serum TNF-
, which was induced by LPS and caused lethal hepatitis, was 10 times up-regulated by the mAb pretreatment. Moreover, this mAb induced antiapoptotic genes in liver in a TLR4/MD-2-dependent manner. These results demonstrated that an agonistic mAb to TLR4/MD-2 protected mice from LPS/D-galactosamine-induced acute lethal hepatitis by delivering a protective signal activating NF-
B through TLR4/MD-2.
This article has been cited by other articles:
![]() |
S. Shoma, K. Tsuchiya, I. Kawamura, T. Nomura, H. Hara, R. Uchiyama, S. Daim, and M. Mitsuyama Critical Involvement of Pneumolysin in Production of Interleukin-1{alpha} and Caspase-1-Dependent Cytokines in Infection with Streptococcus pneumoniae In Vitro: a Novel Function of Pneumolysin in Caspase-1 Activation Infect. Immun., April 1, 2008; 76(4): 1547 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dunn-Siegrist, O. Leger, B. Daubeuf, Y. Poitevin, F. Depis, S. Herren, M. Kosco-Vilbois, Y. Dean, J. Pugin, and G. Elson Pivotal Involvement of Fc{gamma} Receptor IIA in the Neutralization of Lipopolysaccharide Signaling via a Potent Novel Anti-TLR4 Monoclonal Antibody 15C1 J. Biol. Chem., November 30, 2007; 282(48): 34817 - 34827. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahashi, T. Shibata, S. Akashi-Takamura, T. Kiyokawa, Y. Wakabayashi, N. Tanimura, T. Kobayashi, F. Matsumoto, R. Fukui, T. Kouro, et al. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses J. Exp. Med., November 26, 2007; 204(12): 2963 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohta, U. Bahrun, R. Shimazu, H. Matsushita, K. Fukudome, and M. Kimoto Induction of Long-Term Lipopolysaccharide Tolerance by an Agonistic Monoclonal Antibody to the Toll-Like Receptor 4/MD-2 Complex Clin. Vaccine Immunol., October 1, 2006; 13(10): 1131 - 1136. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |